Panacea Life Sciences Hldgs Inc (EXDID)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EXDID | ABT | SYK | BSX | MDT |
| Company | Panacea Life Sciences Hldgs Inc | Abbott Laboratories | Stryker Corp | Boston Scientific Corp | Medtronic Inc |
| Price Information | |||||
| Exchange | OTC US | NYSE | NYSE | NYSE | NYSE |
| Open | 1.1200 | 112.31 | 362.00 | 83.57 | 89.08 |
| High | 1.1200 | 112.93 | 363.50 | 83.69 | 89.57 |
| Low | 1.0000 | 112.10 | 358.31 | 82.59 | 88.51 |
| Last | 1.0000 | 112.73 | 361.35 | 83.08 | 89.45 |
| Change | unch | +0.12 | +1.85 | -0.42 | +0.06 |
| % Change | unch | +0.11% | +0.51% | -0.50% | +0.07% |
| Volume | 4,800 | 3,508,682 | 1,431,782 | 4,066,920 | 6,320,238 |
| 20-Day Average Volume | 2,644 | 4,834,095 | 1,133,960 | 5,384,415 | 7,516,405 |
| Previous Close | 1.0000 | 112.61 | 359.50 | 83.50 | 89.39 |
| Industry | Medical Products | Medical Products | Medical Products | Medical Products | Medical Products |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.3564 | 114.87 | 363.15 | 82.73 | 89.61 |
| 20-Day Raw Stochastic | 0.00% | 13.15% | 35.06% | 66.23% | 52.11% |
| 20-Day Relative Strength | 36.24% | 50.38% | 56.25% | 60.91% | 59.09% |
| Weighted Alpha | -90.93 | +14.58 | +29.57 | +56.31 | +16.27 |
| Today's Opinion | 100% Sell | 64% Buy | 88% Buy | 100% Buy | 72% Buy |
| Previous Opinion | 100% Sell | 64% Buy | 88% Buy | 100% Buy | 72% Buy |
| Last Month's Opinion | 96% Sell | 56% Buy | 40% Buy | 88% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -16.67% since 11/16/21 | -1.24% since 09/19/24 | -1.01% since 09/19/24 | -0.75% since 09/19/24 | -0.02% since 09/19/24 |
| Low | 1.0000 on 11/24/21 | 111.85 on 09/25/24 | 358.31 on 09/26/24 | 82.59 on 09/26/24 | 88.51 on 09/26/24 |
| High | 1.1500 on 11/19/21 | 114.90 on 09/23/24 | 368.74 on 09/23/24 | 84.71 on 09/23/24 | 90.40 on 09/25/24 |
| 1-Month | |||||
| %Chg | -50.94% since 10/22/21 | +0.03% since 08/26/24 | +1.99% since 08/26/24 | +4.54% since 08/26/24 | +0.12% since 08/26/24 |
| Low | 1.0000 on 11/24/21 | 111.85 on 09/25/24 | 353.60 on 08/28/24 | 79.03 on 08/28/24 | 87.23 on 08/30/24 |
| High | 2.0440 on 10/27/21 | 118.54 on 09/17/24 | 374.63 on 09/16/24 | 84.89 on 09/19/24 | 91.49 on 09/04/24 |
| 3-Month | |||||
| %Chg | -56.92% since 08/24/21 | +7.48% since 06/26/24 | +6.12% since 06/26/24 | +7.76% since 06/26/24 | +11.74% since 06/26/24 |
| Low | 1.0000 on 11/24/21 | 99.71 on 07/18/24 | 314.93 on 08/05/24 | 71.88 on 08/05/24 | 75.96 on 07/09/24 |
| High | 3.3264 on 10/18/21 | 118.54 on 09/17/24 | 374.63 on 09/16/24 | 84.89 on 09/19/24 | 91.49 on 09/04/24 |
| 6-Month | |||||
| %Chg | -64.29% since 05/24/21 | +1.10% since 03/26/24 | +3.13% since 03/26/24 | +22.28% since 03/26/24 | +6.87% since 03/26/24 |
| Low | 1.0000 on 11/24/21 | 99.71 on 07/18/24 | 314.93 on 08/05/24 | 66.80 on 04/22/24 | 75.96 on 07/09/24 |
| High | 5.5720 on 07/01/21 | 118.54 on 09/17/24 | 374.63 on 09/16/24 | 84.89 on 09/19/24 | 91.49 on 09/04/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 21,564 | 195,900,176 | 136,951,536 | 122,502,512 | 114,622,120 |
| Shares Outstanding, K | 21,564 | 1,739,634 | 380,950 | 1,467,096 | 1,282,270 |
| Annual Sales | 2,070,000 | 40,109,000,000 | 20,498,000,000 | 14,240,000,000 | 32,364,000,000 |
| Annual Net Income | -9,460,000 | 5,723,000,000 | 3,165,000,000 | 1,591,000,000 | 3,677,000,000 |
| Last Quarter Sales | 5,070,000 | 10,377,000,000 | 5,422,000,000 | 4,120,000,000 | 7,915,000,000 |
| Last Quarter Net Income | 120,000 | 1,302,000,000 | 825,000,000 | 324,000,000 | 1,043,000,000 |
| 60-Month Beta | 3.97 | 0.72 | 0.91 | 0.79 | 0.84 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 1.14 on 07/18/24 | 2.81 on 07/30/24 | 0.62 on 07/24/24 | 1.23 on 08/20/24 |
| Latest Earnings Date | 12/01/21 | 10/16/24 | 11/07/24 | 10/24/24 | 11/19/24 |
| Most Recent Dividend | N/A | 0.550 on 07/15/24 | 0.800 on 06/28/24 | N/A | 0.700 on 09/27/24 |
| Next Ex-Dividends Date | N/A | 10/15/24 | 06/28/24 | N/A | 09/27/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.47 | 32.15 | 37.45 | 17.13 |